Sep. 2 at 5:43 PM
$COGT w/ 2 drugs this year, and another one coming shortly, there's too much execution risk in launching for small bio. FAIRMOUNT FUNDS is on the board w/ 2 seats.. They sold APGE earlier this year. FAIRMOUNT holds no position in commercial bio, that isn't their motto. They did sell over 10.5m shares this year. ( taking profit ) holds around 5m shares. They also sold APGE 1,750,000 Jan before the buyout later in the year, but bought back 770k in March. FAIRMOUNT sold COGT in Jan ( 3.5m shares ) & March ( 7 million shares). today they have 5m shares.. So just 3%... if you think that M&A is in play, look for some buys in Sept/Oct/Nov by FAIRMOUNT.. if not, then FAIRMOUNT may not want to stick around. It'll be interesting to see...
